Article: Other News To Note.

o Agilent Technologies Inc., of Palo Alto, Calif., formed a collaboration with the Translational Genomics Research Institute (TGen), of Phoenix, on an application for oligonucleotide microarray technology, called comparative genomic hybridization, that could enhance the ability to identify and locate genetic alterations that contribute to cancer. TGen gains early access to Agilent's CGH microarrays and computational tools for analyzing and visualizing CGH data and combined CGH and gene expression profile data. The effort builds on a six-year, ongoing collaboration on gene expression profiling.

o Antisense Therapeutics Ltd., of Melbourne, Australia, and Isis ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!